All Stories

  1. Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1

    Article • Journal of Clinical Medicine, October 2024, MDPI AG

    MD PhD Diederik Meindert Somford

  2. The Anti-Tumor Effects of the Fetal Estrogen Estetrol in Advanced Prostate Cancer

    Article • June 2024, MDPI AG

    MD PhD Diederik Meindert Somford

  3. Validation of Claims Data for Absorbing Pads as a Measure for Urinary Incontinence after Radical Prostatectomy, a National Cross-Sectional Analysis

    Article • Cancers, December 2023, MDPI AG

    MD PhD Diederik Meindert Somford

  4. Optimization of Preoperative Lymph Node Staging in Patients with Muscle-Invasive Bladder Cancer Using Radiomics on Computed Tomography

    Article • Journal of Personalized Medicine, April 2022, MDPI AG

    MD PhD Diederik Meindert Somford

  5. RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer

    Article • Cancers, December 2021, MDPI AG

    MD PhD Diederik Meindert Somford

  6. Intermitterende torsio testis: verdraaid belangrijk om te (h)erkennen

    Article • Huisarts en Wetenschap, May 2020, Springer Science + Business Media

    MD PhD Diederik Meindert Somford

  7. Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?

    Article • European Urology Oncology, April 2020, Elsevier

    MD PhD Diederik Meindert Somford

  8. Prostate biopsy techniques and pre-biopsy prophylactic measures: variation in current practice patterns in the Netherlands

    Article • BMC Urology, March 2020, Springer Science + Business Media

    MD PhD Diederik Meindert Somford

  9. Complications and Adverse Events of Three Magnetic Resonance Imaging–based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial

    Article • European Urology Oncology, November 2019, Elsevier

    MD PhD Diederik Meindert Somford

  10. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients

    Article • European Urology Oncology, October 2018, Elsevier

    MD PhD Diederik Meindert Somford

  11. Incidence and Risk Factors of Postoperative Urinary Retention and Bladder Catheterization in Patients Undergoing Fast-Track Total Joint Arthroplasty: A Prospective Observational Study on 371 Patients

    Article • The Journal of Arthroplasty, May 2018, Elsevier

    MD PhD Diederik Meindert Somford

  12. PD23-02 THE FUTURE TRIAL; A MULTICENTER RCT ON THREE TECHNIQUES OF MRI TARGETED PROSTATE BIOPSY.

    Article • The Journal of Urology, April 2018, Wolters Kluwer Health

    MD PhD Diederik Meindert Somford

  13. Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma

    Article • Therapeutic Drug Monitoring, April 2018, Wolters Kluwer Health

    MD PhD Diederik Meindert Somford

  14. The FUTURE trial: A RCT on MRI targeted prostate biopsy. Comparison of targeted and systematic biopsy outcomes

    Article • European Urology Supplements, March 2018, Elsevier

    MD PhD Diederik Meindert Somford

  15. Drug-drug interaction potential in men treated with enzalutamide: Mind the gap

    Article • British Journal of Clinical Pharmacology, October 2017, Wiley

    Inge Van oort, MD PhD Diederik Meindert Somford

  16. An Ex Vivo Phantom Validation Study of an MRI-Transrectal Ultrasound Fusion Device for Targeted Prostate Biopsy

    Article • Journal of Endourology, June 2016, Mary Ann Liebert Inc

    MD PhD Diederik Meindert Somford

  17. Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide

    Article • Clinical Pharmacokinetics, April 2016, Springer Science + Business Media

    MD PhD Diederik Meindert Somford

  18. Editorial Comment

    Article • The Journal of Urology, September 2013, Wolters Kluwer Health

    MD PhD Diederik Meindert Somford

  19. Re: Markus Graefen, Thorsten Schlomm. Active Surveillance for Low-risk Prostate Cancer: Some Questions Are Answered, but Many Questions Remain. Eur Urol 2013;63:604–5

    Article • European Urology, September 2013, Elsevier

    MD PhD Diederik Meindert Somford

  20. Radicale prostatectomie in Nederland

    Article • Tijdschrift voor Urologie, March 2013, Springer Science + Business Media

    MD PhD Diederik Meindert Somford

  21. Relationship between Apparent Diffusion Coefficients at 3.0-T MR Imaging and Gleason Grade in Peripheral Zone Prostate Cancer

    Article • Radiology, May 2011, Radiological Society of North America (RSNA)

    MD PhD Diederik Meindert Somford

  22. Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy

    Article • World Journal of Urology, January 2011, Springer Science + Business Media

    MD PhD Diederik Meindert Somford

  23. Magnetic Resonance Imaging Guided Prostate Biopsy in Men With Repeat Negative Biopsies and Increased Prostate Specific Antigen

    Article • The Journal of Urology, February 2010, Wolters Kluwer Health

    MD PhD Diederik Meindert Somford

  24. VALUE OF 3 TESLA MULTI-MODALITY DIRECTED MR GUIDED BIOPSY TO DETECT PROSTATE CANCER IN PATIENTS AFTER AT LEAST TWO PREVIOUS NEGATIVE BIOPSIES AND ELEVATED PSA

    Article • The Journal of Urology, April 2009, Wolters Kluwer Health

    MD PhD Diederik Meindert Somford

  25. Diffusion and Perfusion MR Imaging of the Prostate

    Article • Magnetic Resonance Imaging Clinics of North America, November 2008, Elsevier

    MD PhD Diederik Meindert Somford

  26. Proximal and Distal Hyperattenuating Middle Cerebral Artery Signs at CT: Different Prognostic Implications

    Article • Radiology, June 2002, Radiological Society of North America (RSNA)

    MD PhD Diederik Meindert Somford